haemoglobinopathies and thalassaemia Flashcards

1
Q

Describe the relationship between haemoglobinopath and thalassaemias.

A

Haemoglobinopathies involve molecular defects in the haemoglobin protein, while thalassaemias result from defects in the synthesis of globin chains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the difference between a haemoglobinopathy and thalassaemia in terms of defect type?

A

Haemoglobinopathy is a qualitative defect due to a mutation in the coding sequence of a globin gene, while thalassaemia is a quantitative defect caused by a mutation in the non-coding sequence of a globin gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do haemoglobinopathies and thalassaemias overlap?

A

Some thalassaemias can also be haemoglobinopathies, as conditions affecting globin proteins may also impact their production.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define sickle cell disease.

A

Sickle cell disease is a condition where a mutation in a single amino acid leads to the clinical symptoms of sickle cell anaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the consequence of a Glu to Val mutation in haemoglobin?

A

The mutation causes self-association and polymerization of haemoglobin tetramers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does the Glu to Val mutation in haemoglobin lead to polymerization?

A

The Val-6 on one subunit binds to a hydrophobic patch on another subunit, initiating a chain reaction of binding between subunits.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the polymerization process of haemoglobin S in sickle cell disease.

A

The Glu to Val mutation causes subunits to bind to each other, forming long chains of hemoglobin tetramers, leading to polymerization.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What facilitates the polymerization of hemoglobin S in sickle cell disease?

A

The process is facilitated by the very high concentration of hemoglobin in erythrocytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does the crystal structure of sickle-cell deoxyhemoglobin contribute to understanding the disease?

A

It reveals the arrangement of subunits and the binding pattern that leads to polymerization, providing insights into the molecular basis of sickle cell disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the polymerization process of hemoglobin S.

A

Polymerization of hemoglobin S involves the binding of Val-6 on one β-subunit to the “hydrophobic patch” on another β-subunit in a different tetramer, leading to the formation of strands with a regular, symmetrical helical structure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the effect of hemoglobin fibers on the shape of erythrocytes in sickle cell disease?

A

Growing fibers of HbS distort the shape of erythrocytes from a bi-concave disc to an irregular shape, ultimately resulting in the characteristic sickle cell shape.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define sickle cell crisis in sickle cell disease.

A

Sickle cell crisis refers to episodes where symptoms of sickle cell disease are exacerbated, leading to acute pain and other complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do genetics play a role in sickle cell disease?

A

Genetics contribute to sickle cell disease by causing the abnormal hemoglobin S to polymerize under certain conditions, leading to the characteristic symptoms of the disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the therapies used for sickle cell disease.

A

Therapies for sickle cell disease include transfusion, attempts to induce expression of fetal hemoglobin (HbF), and the use of hydroxyurea to reduce erythrocyte sickling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the risk factors that can trigger sickle cell crisis?

A

Risk factors for sickle cell crisis include exercise, altitude, cold, dehydration, alcohol consumption, pregnancy, and infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do hemoglobin fibers contribute to the symptoms of sickle cell disease?

A

Hemoglobin fibers lead to the distortion of erythrocyte shape, increased fragility, and clumping of cells, causing blockages in microcirculation and various symptoms of sickle cell disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the structure of hemoglobin fibers formed in sickle cell disease.

A

Hemoglobin fibers in sickle cell disease consist of regular 14-strand helical structures formed by the alignment of strands, resulting from the polymerization of hemoglobin S.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the role of fetal hemoglobin (HbF) in the treatment of sickle cell disease?

A

Fetal hemoglobin (HbF) is used in therapies for sickle cell disease to reduce erythrocyte sickling, as it does not participate in the polymerization process like hemoglobin S.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How do interactions differ between normal hemoglobin and hemoglobin S in sickle cell disease?

A

Normal hemoglobin interrupts polymer formation by not having Val-6 and thus prevents the formation of hemoglobin fibers, unlike hemoglobin S which leads to the characteristic symptoms of sickle cell disease.

20
Q

Describe the potential impact of a certain treatment on baboons regarding HbF induction.

A

Shown to induce HbF in baboons.

21
Q

Explain the possible mechanism by which a treatment may affect DNA methylation and transcription of globin genes.

A

Possibly affects DNA methylation (and therefore transcription) of globin genes.

22
Q

What are some characteristics of other haemoglobinopathies compared to HbS?

A

Includes other mutations at Glu-6 in β-subunit, but do not lead to formation of Hb fibres (Ala, Lys, Gln).

23
Q

Define polycythemia/erythrocytosis.

A

Over-production of erythrocytes.

24
Q

Describe the consequences of the lack of histidine in HbIwate and HbHyde Park.

A

Can’t bind O2 to affected subunit, affects overall O2 affinity of tetramer, blue/brown color, cyanosis.

25
Q

Explain the activation and inactivation of globin genes during development.

A

Globin genes are activated (and inactivated) sequentially during development.

26
Q

What is the most common cause of α-thalassaemia?

A

Most common cause is deletion of α-globin gene.

27
Q

Describe the formation of unstable tetramers in HbH disease and Hydrops fetalis.

A

HbH disease = unstable tetramers of excess β-chains formed, Hydrops fetalis = unstable tetramers of γ-chains formed.

28
Q

Describe the general characteristics of thalassaemia.

A

Thalassaemia is usually fatal, involves defects in globin chain synthesis, and can manifest as mild or severe forms.

29
Q

Define Hb H disease.

A

Hb H disease is characterized by the presence of abnormal hemoglobin due to deletions of α-globin genes.

30
Q

How does α-thalassaemia affect globin chains and lead to anemia?

A

In α-thalassaemia, the lack of α-globin chains causes lower levels of α2β2 and α2γ2, resulting in mild to severe anemia.

31
Q

Describe the impact of thalassaemia on fetal hemoglobin.

A

β-thalassaemia does not affect fetal hemoglobin.

32
Q

What are the consequences of excess α-globin chains in β-thalassaemia?

A

Excess α-globin chains in β-thalassaemia can damage erythrocyte membranes, leading to hemolytic anemia.

33
Q

What treatment is required for thalassaemia patients to survive?

A

Regular blood transfusions every 2-4 weeks are necessary for survival, leading to potential iron overload.

34
Q

How does iron overload in thalassaemia affect the body?

A

Iron overload in thalassaemia can be toxic to the heart, leading to cardiac hypertrophy, dilated cardiomyopathy, and congestive heart failure.

35
Q

Define chelation therapy in the context of thalassaemia treatment.

A

Chelation therapy is used to remove excess iron accumulated from regular blood transfusions in thalassaemia patients to prevent organ damage.

36
Q

Describe the treatment approach involving Deferoxamine for β-thalassaemia.

A

Deferoxamine is administered through overnight infusion 5-6 times a week for the treatment of β-thalassaemia.

37
Q

Define Haemolytic anaemia and its consequences.

A

Haemolytic anaemia is a type of anaemia caused by abnormal destruction of red cells, leading to a release of cell contents that can cause damage. Consequences can range from mild to severe.

38
Q

How do symptoms of haemoglobinopathies and thalassaemias vary despite being defects in haemoglobin?

A

Symptoms vary widely due to the particular mutation, number of affected alleles, and the influence of secondary and tertiary modifiers, as well as environmental factors.

39
Q

Do haemoglobinopathies affect a large number of individuals globally?

A

Yes, haemoglobinopathies affect a large number of individuals, with approximately 7% of the global population carrying an allele.

40
Q

Describe the possibility of a ‘compound’ disease in the context of thalassaemias.

A

Thalassaemias may lead to a ‘compound’ disease due to the heterogeneity of mutations at the β-globin locus, the influence of modifiers, and various environmental factors.

41
Q

Define Vaso-occlusion and its typical occurrence.

A

Vaso-occlusion refers to the blockage of blood vessels, usually occurring in the micro-circulation, particularly in capillaries.

42
Q

What is Splenomegaly and why is it often present in haemolytic anaemia?

A

Splenomegaly is the enlargement of the spleen and is often present in haemolytic anaemia due to the increased need for removal of defective red cells.

43
Q

Explain the term Polycythemia and its implications.

A

Polycythemia refers to an increased volume of blood occupied by red cells, which can result from overproduction of red cells or reduced blood plasma volume.

44
Q

Describe the term Dyspnea and its significance in medical contexts.

A

Dyspnea refers to shortness of breath or breathlessness, commonly observed in various medical conditions.

45
Q

What is the treatment approach involving bone marrow transplantation for haemoglobinopathies?

A

Bone marrow transplantation is a treatment option for some haemoglobinopathies, aiming to replace defective bone marrow with healthy marrow to improve blood cell production.